Interestingly, when exogenously administered, TRAIL exerts a potent tumoricidal activity on cancer cells in vitro and in vivo, without significant effects on normal cells, pointing to its strong therapeutic potential [8]. This evidence concerns the gene TNFSF10 and cancer.